In a filing, Vir Biotechnology Inc revealed its EVP and General Counsel de Verneuil Vanina unloaded Company’s shares for reported $22225.0 on Nov 05 ’24. In the deal valued at $9.47 per share,2,347 shares were sold. As a result of this transaction, de Verneuil Vanina now holds 61,370 shares worth roughly $0.59 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, de Verneuil Vanina sold 1,403 shares, generating $10,107 in total proceeds. Upon selling the shares at $7.20, the EVP and General Counsel now owns 63,717 shares.
Before that, VANINA DE VERNEUIL bought 2,347 shares. Vir Biotechnology Inc shares valued at $21,991 were divested by the Officer at a price of $9.37 per share.
JP Morgan downgraded its Vir Biotechnology Inc [VIR] rating to a Neutral from a an Overweight in a research note published on January 29, 2024; the price target was decreased to $9 from $23. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early September from “a Buy” to “a Neutral”. JP Morgan also remained covering VIR and has increased its forecast on March 06, 2023 with a “an Overweight” recommendation from previously “Neutral” rating. Goldman revised its rating on February 21, 2023. It rated VIR as “a Buy” which previously was an “a Neutral”.
Price Performance Review of VIR
On Tuesday, Vir Biotechnology Inc [NASDAQ:VIR] saw its stock jump 2.88% to $9.64. Over the last five days, the stock has gained 26.68%. Vir Biotechnology Inc shares have fallen nearly -4.17% since the year began. Nevertheless, the stocks have risen 10.05% over the past one year. While a 52-week high of $13.09 was reached on 06/05/24, a 52-week low of $7.12 was recorded on 11/01/24. SMA at 50 days reached $7.80, while 200 days put it at $9.21.
Levels Of Support And Resistance For VIR Stock
The 24-hour chart illustrates a support level at 9.34, which if violated will result in even more drops to 9.05. On the upside, there is a resistance level at 9.79. A further resistance level may holdings at 9.95. The Relative Strength Index (RSI) on the 14-day chart is 76.44, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.45, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 3.82%. Stochastics %K at 87.91% indicates the stock is a selling.
How much short interest is there in Vir Biotechnology Inc?
A steep rise in short interest was recorded in Vir Biotechnology Inc stocks on 2024-10-15, dropping by -0.41 million shares to a total of 5.55 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 5.97 million shares. There was a decline of -7.48%, which implies that there is a negative sentiment for the stock.
